Can hydroxyzine be used to treat anxiety in a 12-year-old girl, and what is the appropriate dosing and safety monitoring?

Hydroxyzine is NOT recommended for treating anxiety disorders in a 12-year-old girl

Hydroxyzine lacks evidence for efficacy in pediatric anxiety disorders and should not be used as a treatment option. The 2020 American Academy of Child and Adolescent Psychiatry (AACAP) guidelines clearly establish that SSRIs and cognitive-behavioral therapy (CBT) are the evidence-based treatments for anxiety disorders in children and adolescents, with no mention of hydroxyzine as a therapeutic option 1.

Why Hydroxyzine Should Not Be Used

Lack of Evidence for Anxiety Disorders

• Hydroxyzine is FDA-approved for symptomatic relief of anxiety and tension in adults, but there is no evidence supporting its use for treating anxiety disorders in children 2
• The drug label does not include pediatric anxiety disorders as an indication 2
• Research shows hydroxyzine was ineffective in controlling preoperative anxiety in children aged 2-16 years 3
• Systematic reviews of pharmacotherapy for pediatric anxiety disorders do not support hydroxyzine use 4, 5

Safety Concerns Specific to This Population

The FDA label highlights several concerning risks 2:

• QT prolongation and Torsade de Pointes have been reported, particularly problematic in younger patients
• CNS depression and sedation can cause confusion and oversedation
• Acute Generalized Exanthematous Pustulosis (AGEP) is a rare but serious skin reaction
• Potentiation of other CNS depressants requires dose reduction of concomitant medications

What SHOULD Be Used Instead

First-Line Treatment Options

For a 12-year-old girl with an anxiety disorder, start with either:

1. Cognitive-Behavioral Therapy (CBT) alone if symptoms are mild-to-moderate 1

   • CBT has "considerable empirical support as safe and effective" 1
   • No medication side effects or monitoring requirements

2. SSRI medication if symptoms are moderate-to-severe or CBT is unavailable 1

   • Fluoxetine, sertraline, fluvoxamine, or paroxetine have the strongest evidence 1
   • Start low and titrate slowly over 6-12 weeks 1
   • Monitor for suicidal ideation (NNH = 143 vs NNT = 3 for response) 1

3. Combined SSRI + CBT for optimal outcomes in severe cases 1, 6

SSRI Implementation Details

• Dosing timeline: Expect clinically significant improvement by week 6, maximal improvement by week 12 1
• Common side effects (usually transient): nausea, headache, insomnia, appetite changes 1
• Serious monitoring: Watch for suicidal thinking (especially first months and after dose changes), behavioral activation, hypomania 1
• All SSRIs carry a black box warning for suicidal thinking through age 24, but absolute risk is low (1% vs 0.2% placebo) 1

Second-Line Options

• SNRIs (duloxetine is FDA-approved for GAD in children ≥7 years) have some empirical support 1, 6, 7
• Consider if SSRIs are ineffective or not tolerated

What to Avoid

Benzodiazepines are NOT recommended despite historical use 8, 6:

• Insufficient evidence of efficacy in pediatric anxiety disorders
• Risk of dependence, behavioral disinhibition, cognitive impairment 5
• Paradoxical reactions in children 7

Clinical Pitfalls

• Do not use hydroxyzine as a "bridge" medication while waiting for SSRI onset—there's no evidence it works for anxiety disorders
• Do not confuse situational anxiety (where hydroxyzine might be used for preoperative sedation) with anxiety disorders requiring chronic treatment
• Do not delay evidence-based treatment by trying unproven medications first

The evidence is clear: for a 12-year-old with an anxiety disorder, choose CBT, an SSRI, or both—not hydroxyzine 1, 6.